Donegal Group Inc. Reports 3rd Quarter Net Income Rise

By Greg Peters • Tuesday, October 07 06:03 • Permanent Link

Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) has announced that it will be releasing its third-quarter results for the period ended September 30, 2025, on Thursday, October 30, 2025, before the opening of regular trading on the NASDAQ Stock Market. The company will also provide a supplemental investor presentation on its website at investors.donegalgroup.com concurrently with its earnings press release.

In the third quarter of 2025, Donegal Group Inc. reported a net income of $9.5 million, compared to $7.8 million in the same period last year. Gross premiums written for the quarter totaled $196.3 million, reflecting an increase from $182.7 million in the third quarter of 2024. The company's combined ratio for the quarter was 94.2%, an improvement from 96.8% in the prior-year period.

Investment income for the third quarter of 2025 amounted to $4.2 million, up from $3.9 million in the third quarter of 2024. Total revenues for the quarter reached $193.6 million, compared to $181.2 million in the same period last year.

Donegal Group Inc. continues to focus on achieving sustained excellent financial performance, strategically modernizing its operations and processes, capitalizing on growth opportunities, and providing superior experiences to its agents, customers, and employees.

The Class A common stock and Class B common stock of Donegal Group Inc. trade on the NASDAQ Global Select Market under the symbols DGICA and DGICB, respectively. The company's insurance subsidiaries and affiliates offer property and casualty lines of insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states, and the Donegal Insurance Group has an A.M. Best rating of A (Excellent). Today the company's shares have moved 1.19% to a price of $19.54. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.